<DOC>
	<DOCNO>NCT00843856</DOCNO>
	<brief_summary>Membranous nephropathy common cause nephrotic syndrome adult . It difficult treat persistent lead end stage renal failure significant number patient . It currently treat institution tacrolimus monotherapy . This effective majority patient reduce proteinuria remission often partial patient tend relapse tacrolimus treatment stop . We propose use mycophenolate mofetil combination tacrolimus aim obtain complete initial response treatment , decrease rate relapse withdrawal therapy less progression renal failure . This randomise control trial , patient randomise receive treatment tacrolimus alone ( current standard therapy ) treatment tacrolimus mycophenolate mofetil . Participants receive treatment 2 year monitor relapse nephrotic syndrome . Study Hypothesis : When mycophenolate mofetil add tacrolimus treatment membranous glomerulonephritis likely improve initial response treatment reduce risk relapse stop therapy .</brief_summary>
	<brief_title>Mycophenolate Mofetil Tacrolimus Versus Tacrolimus Treatment Idiopathic Membranous Glomerulonephritis ( IMG )</brief_title>
	<detailed_description />
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Idiopathic membranous glomerulonephritis renal biopsy Proteinuria protein/creatinine ratio ( PCR ) &gt; 100 unit hypoalbuminaemia PCR &gt; 300 unit normal serum albumin despite 3 month treatment maximum tolerate dos ace inhibitor angiotensin 2 antagonist ( short life threaten complication nephrotic syndrome require institution immediate immunosuppression ) Male female patient age 18 80 year Hepatitis B hepatitis C HIV positive Malignancy ( patient must CT chest abdomen pelvis investigation clinically indicate ) Untreated infection Females pregnant , breast feeding , risk pregnancy use medically acceptable form contraception Any condition judge investigator would cause study detrimental patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>